BetterUp Canada launches Ontario Frontline Study to test mental health coaching
BetterUp Canada's Ontario study tests six months of virtual coaching for first responders, examining stress, resilience and workplace mental health.
Medical Devices & Diagnostics
Features & Analysis
Gilead is licensing once-yearly lenacapavir before Phase 3 results. Why take the manufacturing risk now?
Gilead Sciences has expanded royalty-free licensing agreements with six generic manufacturers to cover investigational once-yearly lenacapavir for HIV prevention while the Phase 3 PURPOSE 365 study is still underway. The decision deliberately moves manufacturing and access planning ahead of regulatory certainty, potentially shortening the years-long delay that has historically separated pharmaceutical innovation from broad availability
Pharma & Biotech
FDA clears Shanghai Ark Biopharmaceutical’s ziresovir Phase 2 trial in critically ill infants with RSV
Shanghai Ark Biopharmaceutical Co., Ltd. ((ArkBio) has received authorization from the U.S. Food and Drug Administration (FDA) to conduct a Phase 2 trial of ziresovir, an oral antiviral being developed for infants with severe respiratory syncytial virus infection, including patients requiring treatment in a pediatric intensive care unit. The planned multicenter, randomized, double-blind and placebo-controlled
Pharma & Biotech
A coronavirus antiviral candidate hit Ebola in the lab. How far can Decoy Therapeutics take it?
Decoy Therapeutics reports early Ebola Zaire activity, but potency data, animal validation and funding will determine the D-MAV program.
Features & Analysis
Bayer-backed self-care research highlights referral, affordability and health literacy gaps
Bayer-backed research says self-care can ease health-system strain, but only with safeguards, affordable access and clear referral pathways.
Medical Devices & Diagnostics
Can CoSara’s 30-minute PCR platform close India’s tuberculosis testing gap? The decisive studies have begun
CoSara begins India clinical studies of Co-Diagnostics’ rapid tuberculosis PCR test, but assay clearance and real-world validation remain ahead.
Features & Analysis
Can emergency Ebola treatment centers close Africa’s outbreak response gap?
Find out how Samaritan’s Purse’s Ebola treatment deployment in Congo highlights urgent gaps in outbreak readiness and field care.
Features & Analysis
A rare disease policy shift just landed at the WHO. Could it change hemophilia care worldwide?
Find out how the WHO hemophilia resolution could reshape diagnosis, treatment access, prophylaxis and bleeding disorder care worldwide.
Pharma & Biotech
Why Gilead’s visceral leishmaniasis collaboration with WHO matters beyond drug donation
Gilead’s WHO pact targets kala-azar access, but diagnostics, treatment delivery and East Africa execution will decide the impact.
Features & Analysis
Is endometriosis diagnosis finally moving beyond surgery after years of missed symptoms?
Endometriosis testing is escaping the surgery-first era. Saliva, blood and imaging tools now face the harder test: clinical utility.